Executive Summary: Key Legal and Evidentiary Issues

• Central issue was whether the insured’s negative answers to health questions amounted to fraudulent misrepresentation justifying nullity ab initio of the life insurance contract.
• Evidence showed extensive specialist follow-ups and significant medical history within 24 months of application, contradicting the insured’s “No” answer to being referred to or seen by specialists.
• The court held that a truthful answer to Question 2 would have triggered a full health questionnaire and likely a refusal of coverage under the group underwriting framework.
• The judge found, on the balance of probabilities, that the insured intentionally omitted material information to avoid an adverse risk assessment, satisfying the civil standard for fraud.
• The decision reaffirmed that an insured must not substitute their own view of their health (e.g., feeling “diabetes-free” post-transplant) for the insurer’s assessment of risk.
• As a result of the fraud finding, the policy was declared null from the outset, limiting recovery to a refund of premiums and denying the estate’s claim to the $300,000 benefit and related damages.

Factual background

Robert Hindle applied on 17 July 2014 for life insurance designed to cover the balance on a secured line of credit.¹ He subsequently died on 9 January 2017, and his estate, represented by his widow and liquidator, Susan Hindle, claimed the life insurance proceeds.¹ The estate sought payment of $300,000 under the life insurance, plus about $55,000 in interest that had accrued on the line of credit since Mr. Hindle’s death and an additional $25,000 in damages. TD Life, and ultimately The Canada Life Assurance Company as group insurer, denied coverage, asserting that the policy was void because of fraudulent misrepresentations about Mr. Hindle’s health at the time of application.

Medical history and the post-transplant narrative

Mr. Hindle had been diagnosed with type 1 diabetes in 1964. In 1999, he underwent a simultaneous kidney and pancreas transplant that his surgeon, Dr. André Tchervenkov, described as successful and historic. Following that surgery, he stopped taking insulin and, in his and his family’s eyes, began to live as “diabetes-free,” a formulation later echoed in a posthumous tribute and central to his personal narrative. His transplant, however, required lifelong immunosuppressant medication to prevent organ rejection. After the transplant, he continued to experience health problems that are more common among diabetics, such as a detached retina and a gangrenous toe requiring amputation, though his surgeon emphasized these conditions are not exclusive to diabetics. Medical records nonetheless continued to reference “Type 1 Diabetes” among his conditions in at least one discharge summary in 2007, reflecting that his pre-transplant diagnosis remained part of his documented health profile.

The insurance application and health questions

The dispute focused on Mr. Hindle’s negative answers to three questions in section 2 of the insurance application he completed and signed. The most important were Questions 1 and 2, which asked, within the past 24 months, whether he had consulted a doctor, received treatment or counselling, taken any medication for, or been told he had specified conditions such as diabetes, kidney disease, or other glandular, liver, or kidney disorders, and whether he had been referred for testing, investigation, treatment, or been seen by a specialist. The policy had been in force for more than two years at the time of his death, so non-fraudulent misrepresentation or concealment could not alone lead to nullity; fraud was required. Under Quebec civil law, the insurer bore the burden of proving, on a balance of probabilities, that the insured intentionally misrepresented a material fact to induce issuance of the policy under the terms granted, knowing that without the misrepresentation the insurer might not have issued the policy. If fraud is established, the contract is null ab initio and is deemed never to have existed, requiring restitution of the prestations – in this context, the return of premiums paid.

Policy structure, underwriting process, and materiality

The group life product at issue was underwritten on a simplified basis, using short screening questions rather than a full individual underwriting process. TD Life’s evidence, through witnesses Margaret Leacock and underwriting expert Josée Malboeuf, was that eligibility for this product was determined on a global “yes/no” basis. There were no individualized exclusions or premium loadings: each accepted insured paid the same aggregate rate. Negative answers to the initial screening questions operated as a filter that allowed applications to proceed without detailed health assessment. If an applicant answered “yes” to certain questions, they would be required to fill out a more detailed health questionnaire or undergo a telephone interview, allowing the insurer to evaluate risk more fully. In this context, the court emphasized that such simple screens “play the role of a filter” and depend on the client’s frankness and utmost good faith. A false negative answer deprives the insurer of the “alarm signal” that would otherwise trigger further inquiry. Evidence from Ms. Leacock, supported by references to TD Life’s risk-assessment manual, established that had the company known the true extent of Mr. Hindle’s medical history in the 24 months before July 2014, it would have declined to insure him at all. There was no proof that TD Life’s position departed from what a reasonable insurer would have done in similar circumstances.

Specialist consultations and the core evidentiary conflict

The crucial evidentiary focus was the 24-month period prior to 17 July 2014. During that time, Mr. Hindle was followed two to three times per year, according to his transplant surgeon. He had regular follow-up appointments with his nephrologist, Dr. Cantarovich, including on 5 December 2013 and 17 July 2014 – the very day he completed his insurance application. In 2013 and early 2014 he underwent several eye surgeries and follow-up visits with an ophthalmologic specialist. He was also monitored by a dermatologist because of increased skin cancer risk and had basal cell carcinomas removed from his shoulder in 2013. Notes from December 2013 indicated gastrointestinal issues to be discussed with a specialist, and records in July 2014 indicated that a GI appointment had been cancelled and was to be rescheduled. Against this backdrop, the court considered whether it was reasonable or truthful for Mr. Hindle to answer “No” to Question 2, which asked whether, within the previous 24 months, he had been referred for testing, investigation or treatment, or been seen by a specialist. The plaintiff estate argued that many of these contacts were mere “follow-ups” with an existing team rather than new referrals and that, in substance, they should not be treated as being “seen by a specialist” within the meaning of the question. The court rejected that interpretation as an unduly narrow parsing of plain language. It accepted Ms. Malboeuf’s testimony that the wording of Question 2 did not distinguish routine follow-ups from other specialist visits and was deliberately drafted to avoid ambiguity. On the evidence, the judge found that Mr. Hindle could not reasonably state that he had not been referred to or seen by a specialist in the relevant 24-month period.

Assessment of fraud and the duty of disclosure

The judge first addressed the legal framework. Because the policy had been in force more than two years, the insurer had to prove fraud – that is, intentional misrepresentation of a material fact, made to induce issuance of the policy, with knowledge that disclosure might cause refusal of coverage. The court held that Mr. Hindle’s circumstances, including his extensive specialist follow-up and complex medical history, were clearly material to the assessment of risk for a group life insurer relying on simplified underwriting. Regarding Question 2, the judge concluded that, given the number and type of specialist interventions in those 24 months, it was more likely than not that Mr. Hindle knew that answering “Yes” would prompt more searching inquiries and could jeopardize his eligibility. Instead, he answered “No,” thus avoiding the full questionnaire. The court characterized this as a deliberate omission of information that had a clear impact on his insurability. The judge emphasized that an insured may not replace the insurer’s risk assessment with their own perceptions of their health. Even if, as his surgeon believed, Mr. Hindle was no longer “diabetic” in a clinical sense after the transplant, he remained bound to answer questions about referrals, specialists and ongoing conditions truthfully and completely. With respect to Question 1, which listed conditions including diabetes and diseases or disorders of glands, kidneys or liver, the court reached a subsidiary finding. It accepted that the question did not explicitly mention “transplant,” and that transplants are relatively uncommon and not specifically named in the short screening form. Nonetheless, relying on the Civil Code provision that an insured must disclose all known facts likely to materially influence the insurer in setting the premium, assessing the risk, or deciding to cover it, the judge found that a reasonably informed client in Mr. Hindle’s position could not think his complex history of transplant, surgeries, cancerous cell removal and ongoing immunosuppression exempted him from fuller health disclosure. Even in the absence of an expressly targeted question, his situation was serious and unusual enough that he had an obligation to disclose it. The court saw this duty as consistent with appellate authority holding that insureds with significant, ongoing medical issues must disclose them, even without granular questioning, where they obviously bear on insurability.

Final ruling and financial consequences

Pulling the strands together, the court held that Mr. Hindle should have answered Question 2 in the affirmative, and, on a subsidiary basis, that he should also have answered Question 1 affirmatively. A “Yes” answer to either question would have triggered the full health questionnaire and likely led to a refusal of coverage, as evidenced by the underwriting testimony and manuals. On the balance of probabilities, the court found that his negative answers were intentional misrepresentations of material facts, made to induce the insurer to issue coverage under the group policy, and that he acted knowing that truthful disclosure could jeopardize his application. This constituted fraud within the meaning of the Civil Code. As a result, the court declared the life insurance contract null ab initio, as if it had never existed. It dismissed the estate’s originating application, rejected the claim for the $300,000 death benefit, and denied the associated claims for interest on the line of credit and $25,000 in damages. The only monetary relief ordered was that Canada Life must refund all premiums paid under the policy, quantified at $11,143.95, together with legal costs. The defendants, TD Life and The Canada Life Assurance Company, were thus the successful parties, and while the estate received $11,143.95 as a return of its own premiums, no positive monetary award in favour of the successful defendants was specified beyond an entitlement to costs whose exact amount cannot be determined from the judgment.